From: Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
Clinicopathological parameters | Number of patients(%) | Exosomal miR-184 | ||
---|---|---|---|---|
Low | High | P | ||
Age(years), Median | Â | Â | Â | 0.777 |
 < 60 | 33 | 15 | 18 |  |
 ≥ 60 | 31 | 13 | 18 |  |
Gender | Â | Â | Â | 0.899 |
 Male | 28 | 12 | 16 |  |
 Female | 36 | 16 | 20 |  |
Smoking history | Â | Â | Â | 0.353 |
 Never smoking | 49 | 23 | 26 |  |
 Now/once smoking | 15 | 5 | 10 |  |
ECOG Score | Â | Â | Â | 0.226 |
 0–1 | 53 | 25 | 28 |  |
 ≥ 2 | 11 | 3 | 8 |  |
Primary tumor | Â | Â | Â | 0.705 |
 ≤ 4 cm | 19 | 9 | 10 |  |
 > 4 cm | 45 | 19 | 26 |  |
TNM | Â | Â | Â | 0.317 |
 I–IVA | 25 | 9 | 16 |  |
 IVB | 39 | 19 | 20 |  |
PLT | Â | Â | Â | 0.411 |
 Low(≤ 146) | 13 | 7 | 6 |  |
 High(> 146) | 51 | 21 | 30 |  |
LDH | Â | Â | Â | 0.018* |
 Low(≤ 199) | 29 | 8 | 21 |  |
 High(> 199) | 35 | 20 | 15 |  |
CEA | Â | Â | Â | 0.129 |
 Low(≤ 8.605) | 25 | 8 | 17 |  |
 High(> 8.605) | 39 | 20 | 19 |  |
Distant metastasis | Â | Â | Â | 0.164 |
 No | 17 | 5 | 12 |  |
 Yes | 47 | 23 | 24 |  |
Contralateral lung metastasis | Â | Â | Â | 0.069 |
 No | 24 | 7 | 17 |  |
 Yes | 40 | 21 | 19 |  |
Pleura metastasis | Â | Â | Â | 0.825 |
 No | 33 | 14 | 19 |  |
 Yes | 31 | 14 | 17 |  |
Bone metastasis | Â | Â | Â | Â |
 No | 23 | 9 | 14 |  |
 Yes | 41 | 19 | 22 |  |
Brain metastasis | Â | Â | Â | Â |
 No | 36 | 14 | 22 |  |
 Yes | 28 | 14 | 14 |  |